Physician profile
Devin Trehy
NPI 1356962831
$14,820.31
in general payments reported to CMS, 2019-2025
28 companies · $4,211 in 2025
The $4,211 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,136 · 2023: $3,593 · 2024: $5,880 · 2025: $4,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $288 · Education: $8.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,387.94 |
| Travel and Lodging | $288.18 |
| Education | $8.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,299.74 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $1,814.63 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept |
| Curonix LLC | $1,643.97 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $1,526.45 | 2023-2025 | Proclaim, Eterna, Axium |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,138.72 | 2023-2025 | Relistor |
| Relievant Medsystems, INC. | $1,135.47 | 2022-2023 | Intracept |
| Abbvie INC. | $785.48 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $781.96 | 2023-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $655.65 | 2025 | Senza, Omnia, Corridor |
| Pfizer INC. | $549.38 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $472.81 | 2023-2024 | Quviviq |
| Azurity Pharmaceuticals, INC. | $426.39 | 2023-2025 | Horizant, Horizant |
| Tersera Therapeutics LLC | $421.25 | 2024-2025 | Prialt |
| Zynex Medical, INC. | $272.88 | 2023 | Nexwave |
| Nevro Corp. | $244.03 | 2023-2024 | Senza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $220.12 | 2023-2025 | Sprint Pns System |
| Stryker Corporation | $103.53 | 2025 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $82.40 | 2025 | |
| Valinor Pharma, LLC | $49.00 | 2025 | Movantik |
| Lilly USA, LLC | $43.06 | 2022-2023 | Emgality, Reyvow |
| Si-Bone, INC. | $32.78 | 2025 | |
| Almatica Pharma LLC | $21.23 | 2022 | |
| Averitas Pharma INC. | $19.76 | 2025 | Qutenza |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.55 | 2022 | |
| Ibsa Pharma INC. | $17.68 | 2023 | Tirosint, Licart |
| Spinal Simplicity, LLC | $15.97 | 2025 | Ha Minuteman G3-R |
| Vertex Pharmaceuticals Incorporated | $13.76 | 2024 | |
| Nalu Medical, INC. | $13.66 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Trehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.